Skip to main content

Clinical trial G1T48-01

A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Ascending Doses of G1T48 Alone and in Combination with Palbociclib in Women with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer (G1T48-01)

Cancers
Organ Breast
Trial status Trial closed
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 1
Academic trial Non
Sponsor G1 Therapeutics
EudraCT Identifier 2017-004502-17
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03455270
Inclusion criteria Any line/ ER positive/ HER2 negative/ RECIST 1.1
Last update